EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-05-12
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide synthesis workflows. It is not intended for in vivo or clinical applications and requires strict adherence to technical handling and storage protocols for reliable results.
GLT-1 Upregulation Counters TBI via CB1-CREB Pathway Inhibit
2026-05-11
A recent study demonstrates that increasing GLT-1 expression in mice with traumatic brain injury (TBI) reduces neuronal apoptosis and cognitive deficits by disrupting the CB1-CREB signaling axis. This mechanistic insight highlights a new therapeutic target for mitigating glutamate excitotoxicity and cognitive dysfunction after TBI.
Targeting BCL-XL and MCL-1 in Glioblastoma: New Apoptosis St
2026-05-11
The referenced study reveals that glioblastoma (GBM) cells, especially stem-like subpopulations, exhibit heightened apoptotic priming due to elevated anti-apoptotic BCL-XL and MCL-1 expression. Sequential inhibition of these proteins with BH3-mimetics demonstrates robust tumor regression in preclinical models, offering a promising approach to overcome GBM treatment resistance.
Reliable Amide Bond Formation with HATU (SKU A7022): Protoco
2026-05-10
This article addresses reproducible peptide synthesis chemistry using HATU (1-[Bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate), SKU A7022. Through scenario-driven Q&A, we explore validated protocols, data-backed optimization, and vendor selection for biomedical researchers. The focus is on workflow reliability, sensitivity, and proven outcomes in amide and ester formation.
CX-5461: RNA Polymerase I Inhibitor Workflows for Cancer Res
2026-05-09
CX-5461 offers precise, selective inhibition of RNA polymerase I, enabling robust experimental dissection of ribosome biogenesis and its role in solid tumor suppression. This article translates recent high-impact findings into actionable protocols, troubleshooting strategies, and comparative insights for cancer researchers leveraging APExBIO’s trusted reagent.
Pioglitazone: PPARγ Agonist Workflows for Inflammation & Met
2026-05-09
Pioglitazone, a selective PPARγ agonist, enables reproducible modeling of metabolic and inflammatory pathways in diabetes and IBD research. This guide translates recent breakthroughs into actionable workflows, highlighting experimental design, troubleshooting, and protocol optimizations for advanced immunometabolic studies.
Phosphatase Inhibitor Cocktail (2 Tubes, 100X): Protocol and
2026-05-08
The Phosphatase Inhibitor Cocktail (2 Tubes, 100X) addresses the challenge of preserving protein phosphorylation during sample preparation by inhibiting both serine/threonine and tyrosine phosphatases. It is specifically recommended for use in workflows such as immunoblotting, kinase activity assays, and phosphoproteomics, but should not be repurposed for diagnostic or medical applications. The dual-tube design requires precise handling to achieve optimal results.
Afatinib (BIBW 2992) in Assembloid Cancer Models: Workflow &
2026-05-07
Harness the irreversible ErbB family inhibitor Afatinib (BIBW 2992) to dissect EGFR, HER2, and HER4 signaling in patient-derived cancer assembloid systems. This guide outlines optimized protocols, advanced troubleshooting, and actionable insights for studying tumor–stroma interactions and overcoming drug resistance in translational oncology.
WP1066: Advanced JAK2/STAT3 Inhibition for Cancer and Beyond
2026-05-07
Discover how WP1066, a potent JAK2/STAT3 inhibitor, is transforming cancer and regenerative research. This article explores mechanisms, protocol insights, and assay planning based on the latest evidence.
CDK4’s Role in 4E-BP1 Phosphorylation and Cap-Dependent Tran
2026-05-06
This study identifies cyclin-dependent kinase 4 (CDK4) as a novel regulator of 4E-BP1, demonstrating that CDK4 phosphorylates 4E-BP1 at canonical and noncanonical sites to drive cap-dependent translation during the mitosis–G1 transition. These findings expand the landscape of kinase-mediated translational control and suggest new avenues for cancer and cell cycle research.
EZ Cap Cy5 Firefly Luciferase mRNA: Quantitative Tracking &
2026-05-06
Unlock quantitative mRNA delivery tracking and translation efficiency analysis with EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP). This article uniquely connects dual-modality mRNA reporters to nanoparticle manufacturing innovations, guiding advanced assay design and interpretation.
Paclitaxel (Taxol): Mechanistic Benchmarks in Cancer Researc
2026-05-05
Paclitaxel (Taxol) is a highly potent microtubule stabilizer, essential for dissecting cell cycle arrest and apoptosis in cancer research. Its efficacy in ovarian and breast cancer models is benchmarked by precise, low-nanomolar IC50 values and validated angiogenesis inhibition. APExBIO’s Paclitaxel (A4393) is a rigorously characterized tool compound for translational studies.
2-APB: Precision Tool for Calcium Oscillation and Apoptosis
2026-05-05
2-APB (2-aminoethoxydiphenyl borate) uniquely enables researchers to dissect ER-mediated calcium signaling, autophagy, and apoptosis transitions, as elegantly demonstrated in Bombyx mori starvation models. This article delivers actionable protocol guidance, troubleshooting strategies, and workflow enhancements grounded in the latest evidence and APExBIO's proven reagent quality.
Alosetron: 5-HT3 Receptor Antagonist in Gut Polarity Researc
2026-05-04
Alosetron empowers researchers to probe gastrointestinal motility and epithelial polarity by selectively targeting 5-HT3 receptor signaling. This guide details protocol optimization, advanced applications, and troubleshooting strategies for reproducible results in intestinal stem cell and gut homeostasis studies.
BMS 599626 Dihydrochloride: Reliable EGFR/ErbB2 Inhibition f
2026-05-04
This article offers practical, scenario-driven guidance for researchers using BMS 599626 dihydrochloride (SKU B5792) in cell viability and proliferation assays. Learn how this selective EGFR and ErbB2 inhibitor ensures reproducibility, sensitivity, and consistency in cancer biology and senescence research workflows.
458 records 19/31 page Previous Next First page 上5页 1617181920 下5页 Last page